You can:
Name | D(1B) dopamine receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | DRD5 |
Synonym | Gpcr1 DRD1L2 DRD1B dopamine receptor 5 Dopamine D5 receptor [ Show all ] |
Disease | Solid tumours Schizophrenia |
Length | 477 |
Amino acid sequence | MLPPGSNGTAYPGQFALYQQLAQGNAVGGSAGAPPLGPSQVVTACLLTLLIIWTLLGNVLVCAAIVRSRHLRANMTNVFIVSLAVSDLFVALLVMPWKAVAEVAGYWPFGAFCDVWVAFDIMCSTASILNLCVISVDRYWAISRPFRYKRKMTQRMALVMVGLAWTLSILISFIPVQLNWHRDQAASWGGLDLPNNLANWTPWEEDFWEPDVNAENCDSSLNRTYAISSSLISFYIPVAIMIVTYTRIYRIAQVQIRRISSLERAAEHAQSCRSSAACAPDTSLRASIKKETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCSGHPEGPPAGFPCVSETTFDVFVWFGWANSSLNPVIYAFNADFQKVFAQLLGCSHFCSRTPVETVNISNELISYNQDIVFHKEIAAAYIHMMPNAVTPGNREVDNDEEEGPFDRMFQIYQTSPDGDPVAESVWELDCEGEISLDKITPFTPNGFH |
UniProt | P21918 |
Protein Data Bank | N/A |
GPCR-HGmod model | P21918 |
3D structure model | This predicted structure model is from GPCR-EXP P21918. |
BioLiP | N/A |
Therapeutic Target Database | T46828 |
ChEMBL | CHEMBL1850 |
IUPHAR | 218 |
DrugBank | BE0000145, BE0004889 |
Name | PHA-543613 |
---|---|
Molecular formula | C15H17N3O2 |
IUPAC name | N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]furo[2,3-c]pyridine-5-carboxamide |
Molecular weight | 271.32 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 1 |
XlogP | 1.5 |
Synonyms | AKOS005146334 DTXSID6047284 N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide Dihydrochloride PHA-543613, >=98% (HPLC) IPKZCLGGYKRDES-ZDUSSCGKSA-N [ Show all ] |
Inchi Key | IPKZCLGGYKRDES-ZDUSSCGKSA-N |
Inchi ID | InChI=1S/C15H17N3O2/c19-15(12-7-11-3-6-20-14(11)8-16-12)17-13-9-18-4-1-10(13)2-5-18/h3,6-8,10,13H,1-2,4-5,9H2,(H,17,19)/t13-/m0/s1 |
PubChem CID | 9930121 |
ChEMBL | CHEMBL214268 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Inhibition | >10.0 % | PMID16821801 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417